loadpatents
name:-0.011602878570557
name:-0.004565954208374
name:-0.00048708915710449
Carroll; Brian J. Patent Filings

Carroll; Brian J.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Carroll; Brian J..The latest application filed is for "tetrahydro-isohumulone derivatives, methods of making and using".

Company Profile
0.7.9
  • Carroll; Brian J. - Gig Harbor WA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Tetrahydro-isohumulone derivatives, methods of making and using
Grant 10,343,977 - Konda , et al. July 9, 2
2019-07-09
Tetrahydro-isohumulone Derivatives, Methods Of Making And Using
App 20180297934 - KONDA; Veera ;   et al.
2018-10-18
Tetrahydro-isohumulone derivatives, methods of making and using
Grant 9,828,331 - Konda , et al. November 28, 2
2017-11-28
Tetrahydro-isohumulone Derivatives, Methods Of Making And Using
App 20150119461 - KONDA; Veera ;   et al.
2015-04-30
Cis 3,4-dihydroxy-2-(3-methylbutanoyl)-5-(3-methylbutyl)-4-(4-methylpentan- oyl) cyclopent-2-en-1-one derivatives, substantially enantiomerically pure compositions and methods
Grant 8,829,056 - Carroll , et al. September 9, 2
2014-09-09
Cis 3,4-dihydroxy-2-(3-methylbutanoyl)-5-(3-methylbutyl)-4-(4-methylpentan- Oyl)cyclopent-2-en-1-one Derivatives, Substantially Enantiomerically Pure Compositions And Methods
App 20130217781 - CARROLL; Brian J. ;   et al.
2013-08-22
Cis, 3,4-dihydroxy-2-(3-methylbutanoyl)-5-(3-methylbutyl)-4-(4-methylpenta- noyl)cyclopent-2-en-1-derivatives, substantially enantiomerically pure compositions and methods
Grant 8,410,179 - Carroll , et al. April 2, 2
2013-04-02
CIS 3,4-dihydroxy-2-(3-methylbutanoyl)-5-(3-methylbutyl)-4-(4-methylpentan- oyl)cyclopent-2-en-1-derivatives, substantially enantiomerically pure compositions and methods
Grant 8,410,178 - Carroll , et al. April 2, 2
2013-04-02
Cis, 3,4-dihydroxy-2-(3-methylbutanoyl)-5-(3-methylbutyl)-4-(4-methylpenta- Noyl)cyclopent-2-en-1-one Derivatives, Substantially Enantiomerically Pure Compositions And Methods
App 20130018105 - CARROLL; Brian J. ;   et al.
2013-01-17
Cis 3,4-dihydroxy-2-(3-methylbutanoyl)-5-(3-methylbutyl)-4-(4-methylpentan- Oyl)cyclopent-2-en-1-one Derivatives, Substantially Enantiomerically Pure Compositions And Methods
App 20120108671 - Carroll; Brian J. ;   et al.
2012-05-03
Method For The Purification Of Substituted Cyclopent-2-en-1-one Congeners And Substituted 1,3-cyclopentadione Congeners From A Complex Mixture Using Countercurrent Separation
App 20110275721 - Carroll; Brian J. ;   et al.
2011-11-10
Method For The Purification Of Substituted Cyclopent-2-en-1-one Congeners And Substituted 1,3-cyclopentadione Congeners From A Complex Mixture Using Countercurrent Separation
App 20110257074 - Carroll; Brian J. ;   et al.
2011-10-20
Substituted 1,3-cyclopentadione Multi-target Protein Kinase Modulators Of Cancer, Angiogenesis And The Inflammatory Pathways Associated Therewith
App 20100137449 - Tripp; Matthew L. ;   et al.
2010-06-03

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed